The Adderall Shortage Is Real – Here’s How RxSS Helps Members
We know many members are scrambling to find pharmacies with the common ADHD medication in stock. With this and other drug shortages, RxSS can be an invaluable resource.
Transparency
Humira and the Looming Biosimilar Boom
A wave of FDA-approved biosimilars for Humira and other costly biologics will enter the U.S. market in 2023. What does it mean for patients, payers and plan designs?
No, We’re Not Your Doctor—Just Transparency You Can Trust
Members shouldn’t confuse our clinical suggestions for intervention. Medication decisions are between patient and doctor. RxSS informs those discussions, and makes it easy to make a change.
Considering a PBM’s Savings Tool? 10 Questions to Ask Right Now
Free PBM tools can help members get more from their pharmacy benefits, maybe even save on certain prescriptions. What more can you ask for? Quite a bit, actually.
Success With Point Benefit Solutions Hinges on the Pharmacy Factor
Many point benefits solutions have produced positive results for employers and health plans. However, their full potential depends on medication access and affordability.
Generic Dexilant® Joins the PPI Party, But Plenty of Alternatives Already Have
A widely prescribed acid reflux medication now has an authorized generic available. Good news, but five low-cost proton-pump inhibitor (PPIs) generics often work just as well.
Delays or Not, Employers Should Still Prep for Transparency in Coverage
Despite enforcement delays, group health plans should keep moving toward price transparency. They have more to gain than compliance.
Embrace Transparency and Engagement Will Follow
Rather than simply comply, health plans can use CMS transparency rules to create a better member experience. Engagement and satisfaction are the natural byproducts.
Once a Carrot, Here’s Why Transparency Will Stick
Soon all commercial, Medicare Advantage and employer-sponsored health plans will be required to publish prices for a variety of services, including prescription drugs. A boon for consumers, and an opportunity for plans.
2021 Begins with a Transparent Bang
Within the first 30 days, two separate reports revealed details that have never been available to the public before. Each one exemplifies the value of transparency.
